Longitudinal Changes in Regional Brain Volumes and Cognition of Professional Fighters With Traumatic Encephalopathy Syndrome.


Journal

Neurology
ISSN: 1526-632X
Titre abrégé: Neurology
Pays: United States
ID NLM: 0401060

Informations de publication

Date de publication:
12 09 2023
Historique:
received: 03 01 2023
accepted: 12 05 2023
pmc-release: 12 09 2024
medline: 13 9 2023
pubmed: 29 6 2023
entrez: 28 6 2023
Statut: ppublish

Résumé

Due to current limitations in diagnosing chronic traumatic encephalopathy (CTE) clinically, traumatic encephalopathy syndrome (TES) has been proposed as the clinical presentation of suspected CTE. This study aimed to determine whether there was an association between a clinical diagnosis of TES and subsequent temporal decline in cognitive or MRI volumetric measures. This was a secondary analysis of the Professional Athletes Brain Health Study (PABHS), inclusive of active and retired professional fighters older than 34 years. All athletes were adjudicated as TES positive (TES+) or TES negative (TES-) based on the 2021 clinical criteria. General linear mixed models were used to compare MRI regional brain volumes and cognitive performance between groups. A total of 130 fighters met inclusion criteria for consensus conference. Of them, 52 fighters (40%) were adjudicated as TES+. Athletes with a TES+ diagnosis were older and had significantly lower education. Statistically significant interactions and between-group total mean differences were found in all MRI volumetric measurements among the TES+ group compared with those among the TES- group. The rate of volumetric change indicated a significantly greater increase for lateral (estimate = 5,196.65; 95% CI = 2642.65, 7750.66) and inferior lateral ventricles (estimate = 354.28; 95% CI = 159.90, 548.66) and a decrease for the hippocampus (estimate = -385.04, 95% CI = -580.47, -189.62), subcortical gray matter (estimate = -4,641.08; 95% CI = -6783.98, -2498.18), total gray matter (estimate = -26492.00; 95% CI = -50402.00, -2582.32), and posterior corpus callosum (estimate = -147.98; 95% CI = -222.33, -73.62). Likewise, the rate of cognitive decline was significantly greater for reaction time (estimate = 56.31; 95% CI = 26.17, 86.45) and other standardized cognitive scores in the TES+ group. The 2021 TES criteria clearly distinguishes group differences in the longitudinal presentation of volumetric loss in select brain regions and cognitive decline among professional fighters 35 years and older. This study suggests that a TES diagnosis may be useful in professional sports beyond football, such as boxing and mixed martial arts. These findings further suggest that the application of TES criteria may be valuable clinically in predicting cognitive decline.

Sections du résumé

BACKGROUND AND OBJECTIVES
Due to current limitations in diagnosing chronic traumatic encephalopathy (CTE) clinically, traumatic encephalopathy syndrome (TES) has been proposed as the clinical presentation of suspected CTE. This study aimed to determine whether there was an association between a clinical diagnosis of TES and subsequent temporal decline in cognitive or MRI volumetric measures.
METHODS
This was a secondary analysis of the Professional Athletes Brain Health Study (PABHS), inclusive of active and retired professional fighters older than 34 years. All athletes were adjudicated as TES positive (TES+) or TES negative (TES-) based on the 2021 clinical criteria. General linear mixed models were used to compare MRI regional brain volumes and cognitive performance between groups.
RESULTS
A total of 130 fighters met inclusion criteria for consensus conference. Of them, 52 fighters (40%) were adjudicated as TES+. Athletes with a TES+ diagnosis were older and had significantly lower education. Statistically significant interactions and between-group total mean differences were found in all MRI volumetric measurements among the TES+ group compared with those among the TES- group. The rate of volumetric change indicated a significantly greater increase for lateral (estimate = 5,196.65; 95% CI = 2642.65, 7750.66) and inferior lateral ventricles (estimate = 354.28; 95% CI = 159.90, 548.66) and a decrease for the hippocampus (estimate = -385.04, 95% CI = -580.47, -189.62), subcortical gray matter (estimate = -4,641.08; 95% CI = -6783.98, -2498.18), total gray matter (estimate = -26492.00; 95% CI = -50402.00, -2582.32), and posterior corpus callosum (estimate = -147.98; 95% CI = -222.33, -73.62). Likewise, the rate of cognitive decline was significantly greater for reaction time (estimate = 56.31; 95% CI = 26.17, 86.45) and other standardized cognitive scores in the TES+ group.
DISCUSSION
The 2021 TES criteria clearly distinguishes group differences in the longitudinal presentation of volumetric loss in select brain regions and cognitive decline among professional fighters 35 years and older. This study suggests that a TES diagnosis may be useful in professional sports beyond football, such as boxing and mixed martial arts. These findings further suggest that the application of TES criteria may be valuable clinically in predicting cognitive decline.

Identifiants

pubmed: 37380429
pii: WNL.0000000000207594
doi: 10.1212/WNL.0000000000207594
pmc: PMC10513890
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1118-e1126

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2023 American Academy of Neurology.

Références

Dev Neuropsychol. 2017;42(7-8):446-459
pubmed: 29068702
Br J Sports Med. 2015 Aug;49(15):1007-11
pubmed: 25633832
Neuroimage Clin. 2017 Nov 21;17:616-627
pubmed: 29234598
Int Rev Psychiatry. 2020 Feb;32(1):89-95
pubmed: 31587599
Alzheimers Res Ther. 2014 Sep 24;6(5):68
pubmed: 25580160
Brain. 2018 Mar 1;141(3):822-836
pubmed: 29309542
JAMA. 2014 May 14;311(18):1883-8
pubmed: 24825643
CNS Drugs. 2014 Feb;28(2):147-56
pubmed: 24446248
J Neurotrauma. 2018 Jan 15;35(2):278-285
pubmed: 28990457
Am J Epidemiol. 2013 Jul 15;178(2):280-6
pubmed: 23735309
Brain Pathol. 2015 May;25(3):350-64
pubmed: 25904048
J Neurotrauma. 2016 Jan 1;33(1):157-61
pubmed: 25970145
Radiology. 2017 Nov;285(2):555-567
pubmed: 28741982
Brain Imaging Behav. 2019 Jun;13(3):725-734
pubmed: 29779184
Handb Clin Neurol. 2019;167:337-355
pubmed: 31753141
Aging Dis. 2020 Oct 1;11(5):1082-1090
pubmed: 33014524
Acta Neuropathol Commun. 2021 May 22;9(1):96
pubmed: 34022959
Neuroimage Clin. 2019;24:102025
pubmed: 31670152
AJNR Am J Neuroradiol. 2009 Mar;30(3):578-80
pubmed: 19112065
J Neurotrauma. 2005 Nov;22(11):1303-10
pubmed: 16305318
Alzheimers Dement. 2021 Oct;17(10):1709-1724
pubmed: 33826224
Hum Brain Mapp. 2019 Dec 1;40(17):5108-5122
pubmed: 31403734
Neurology. 2021 May 4;96(18):848-863
pubmed: 33722990
Arch Clin Neuropsychol. 2006 Oct;21(7):623-43
pubmed: 17014981
Br J Sports Med. 2023 Apr;57(7):389-394
pubmed: 36517216
Neuroimage Clin. 2018 May 14;19:551-558
pubmed: 29984163
Neurology. 2020 Jan 21;94(3):e232-e240
pubmed: 31871218
JAMA Neurol. 2020 Jan 1;77(1):35-42
pubmed: 31498371

Auteurs

Brooke D Conway Kleven (BD)

From the School of Public Health (B.D.C.K., L.-C.C., B.L., C.L.C., A.M.), University of Nevada, Las Vegas; and Cleveland Clinic Lou Ruvo Center for Brain Health (A.R., R.R., A.M., C.B.), Las Vegas, NV. brooke.conway-kleven@unlv.edu.

Lung-Chang Chien (LC)

From the School of Public Health (B.D.C.K., L.-C.C., B.L., C.L.C., A.M.), University of Nevada, Las Vegas; and Cleveland Clinic Lou Ruvo Center for Brain Health (A.R., R.R., A.M., C.B.), Las Vegas, NV.

Brian Labus (B)

From the School of Public Health (B.D.C.K., L.-C.C., B.L., C.L.C., A.M.), University of Nevada, Las Vegas; and Cleveland Clinic Lou Ruvo Center for Brain Health (A.R., R.R., A.M., C.B.), Las Vegas, NV.

Chad L Cross (CL)

From the School of Public Health (B.D.C.K., L.-C.C., B.L., C.L.C., A.M.), University of Nevada, Las Vegas; and Cleveland Clinic Lou Ruvo Center for Brain Health (A.R., R.R., A.M., C.B.), Las Vegas, NV.

Aaron Ritter (A)

From the School of Public Health (B.D.C.K., L.-C.C., B.L., C.L.C., A.M.), University of Nevada, Las Vegas; and Cleveland Clinic Lou Ruvo Center for Brain Health (A.R., R.R., A.M., C.B.), Las Vegas, NV.

Rebekah Randall (R)

From the School of Public Health (B.D.C.K., L.-C.C., B.L., C.L.C., A.M.), University of Nevada, Las Vegas; and Cleveland Clinic Lou Ruvo Center for Brain Health (A.R., R.R., A.M., C.B.), Las Vegas, NV.

Arturo Montes (A)

From the School of Public Health (B.D.C.K., L.-C.C., B.L., C.L.C., A.M.), University of Nevada, Las Vegas; and Cleveland Clinic Lou Ruvo Center for Brain Health (A.R., R.R., A.M., C.B.), Las Vegas, NV.

Charles Bernick (C)

From the School of Public Health (B.D.C.K., L.-C.C., B.L., C.L.C., A.M.), University of Nevada, Las Vegas; and Cleveland Clinic Lou Ruvo Center for Brain Health (A.R., R.R., A.M., C.B.), Las Vegas, NV.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH